CD8A and neoplasm: Indeed, patients under the age of 50 have a lower ratio of CD8+Tregs and are less responsive to anti-PD-1 than older patients, possibly due to the reduced ability of PMN-Myeloid-derived suppressor cells to migrate through the less dense and lax matrix to the tumor site (Kugel et al., 2018).